FceP,.Iy (y) is a member of a group of related proteins (the ~-family dimers) that function as signal-transducing components of both Fc receptors and the T cell antigen receptor (TC1K). Analysis of y expression during fetal thymus ontogeny revealed that it is expressed in early thymocytes, before the initiation of clonotypic TC1K-e¢ and TC1K-]3 gene rearrangement but is down-regulated in most adult thymocytes. To explore a possible role for y in thymocyte development, we generated transgenic mice in which this protein was overexpressed at all stages of ontogeny. Overexpression of 3' inhibited the maturation of T cells as well as natural killer (NK) cells. The developmental effects were transgene dose related and correlated with markedly delayed maturation of fetal CD4-CD8-FcRII/III + thymocytes, cells thought to include the progenitors of both T and NK cells. These results suggest that the ~ and y chains serve distinctive functions in thymocyte development and indicate that Fc receptor(s) may play an important role in regulating the differentiation of early progenitor cells within the thymus.
S
ignals transduced by the TCR regulate the stage-specific development and selection (positive and negative) of thymocytes (1, 2) . The signal-transducing potential of the TCR complex is conferred by multiple subunits (the CD3-y, -8, and-e, and the {, ~1, or Fc~RIy chains) that share a conserved structural element, the immunoreceptor tyrosine-based activation motif (ITAM) 1 (3) . A considerable body of evidence supports the current notion that ITAMs, through their ability to facilitate activation of cytoplasmic protein tyrosine kinases, mediate all known TCR effector functions (4) .
The signals that regulate the earliest stages of thymocyte maturation are less understood. Precursor CD4-CD8-TCRthymocytes populate the murine thymus on or about day 12 of gestation (2) . These early thymocytes, which are thought to include the precursors of both T cells and NK ceils (5, 6) progress through multiple stages of differentiation before expressing CD4, CD8, and 0t/]3TCR (2, 7).
l Abbrevtanons used m this paper ADCC, antibody-dependent cellular cytotoxlc~ry; DN, double neganve; DP, double posmve; FCM, multicolor flow cytometry: fd, fetal day; "yTg, 2; transgemc, ITAM, mlmunoreceptor Wrosme-based activation mot~f~ poly(IC), polymosimc-polycytidyhc acid.
Although the molecular events that regulate their transit through these various stages remain uncharacterized, recent evidence suggests that they may receive activating signals through cell surface structures (8) . The majori W of early fetal thymocytes express low affinity receptors for lgG (FcyiKII and/or FcylKIlI) (5) . FcylKIII is also expressed on mature NK cells where it functions as a signal-transducing complex to mediate antibody-dependent cellular cytotoxicity (ADCC), and on a subset of mature T cells (9) . These observations have led to speculation that FcRIII may represent a developmentally important signaling structure in early CD4-CD8-TCR-thymocytes (5) .
In mice, the FcyRIII e~ chain forms a complex with a dimer composed of FcelKIy chains (10, 11) . Initially identified as a subunit of the high affinity lgE receptor, FcelKIy is also a subunit of the high affinity IgG receptor (Fc'ylKI), and in a subset of T cells, functions as a subunit of the TClK complex (12) (13) (14) (15) (16) (17) . The structural and functional similarity between Fc~lKIy and ~ suggests that these proteins are members of a family of signal-transducing proteins whose genes were likely generated by duplication (10, 18) . Although FcelKIy is reportedly expressed in early thymocytes, its potential role in thymocyte development remains controversial. The observation that T cell development is unaffected in mice lacking FcelKI'y argues that its function is not critical for T cell maturation (19) . However, recent experiments indicate that Fc~ receptors on fetal thyrnocytes may transduce developmentally important signals (20) . In this study, we document that FceRIy is expressed early in fetal thymic ontogeny, before the rearrangement and expression of the clonotypic TCI~-(x and TCR- [3 chains . To investigate the role ofFceRI-/in thymocyte development, we generated transgenic mice that express elevated levels of FceI~I',/ at all stages of fetal ontogeny. We found that overexpression of FceRI2~ inhibited the maturation of both T cells and NK cells. The developmental effects were transgene dose related and were correlated with delayed maturation of fetal FcyRII/III + thymocytes into FcyPdI/III-thymocytes. Collectively, these results show that FceRI',/ can regulate the differentiation of an early progenitor cell population within the thymus.
Materials and Methods
DNA Constructs and Microinjection. A 4.8-kb BclI genormc fragment containing the human FceRI',/("/) promoter and coding sequences (18) was cloned into the BamHI site of plasrnxd CD2-B-N2 (21) after removal of the SalI-BamHI fragment containing the human CD2 promoter and minigene. A 9.8-kb fragment composed of the ",/gene and the human CD2 3-pnme enhancer was then generated by digestion with NotI, separated from vector sequences by gel electrophoresis, punfied as described (22) , and used for pronuclear mjecnon. Transgenlc mice were identified by Southern blotting of tail DNA using the human CD2 enhancer sequences as a probe.
Mice. Transgemc mice were generated by injection of zygotes obtained from matings of inbred FVB/N mice. Timed matings were performed with either non Tg FVB/N males × non Tg C57BL/6J females or homozygous 2,551Tg FVB/N males × non Tg C57BL/6J females. The first day of mating was designated as day 0.5. FVB/N × C57BL/6J matings were performed because staining with mAbs 2.4G2 (FcyRII/III) and PK136 (NKI.1) were determined to be superior m the C57BL/6J background; however, the developmental effects of the "yTg were Identical regardless of the background.
RNA Extraction and Analysis. Purification of total thymocyte
RNA and Northern blot analysis were performed as described previously (22 washed twine, and used in a standard 6 h S*Cr-release assay with 2,500 target cells/well m 96-well V-bottom plates. Lysis was performed in RPMI 1640 medium containing 10% heat-inactivated FCS, 10 mM Hepes, and 500 U/ml human IL-2 (HoffmanLaRoche, Nutley, NJ). NK activity was evaluated on the NKsensitive target cell line, YAC-1. ADCC assays were performed essennally as described (5) with the exception that 3 mM rather than 30 mM 2,4,6-tnmtrobenzyl sulfonlc acid was used.
Results

Differential Expression of ~ and FcERI T during Fetal Ontogeny.
To examine the normal pattern of FceRIy (~/) expression during ontogeny, Northern blot analysis was performed on RNA obtained from thymi on sequential days of fetal development. "/transcripts were present on fetal day 13.5, the earliest stage in which the thymus could clearly be identified in situ (Fig. 1) . ~/ mRNA levels were highest at early stages of development (fetal days 13.5-16.5), decreased progressively during late gestation, and were barely detectable in adult thymocytes (Fig. 1) . In contrast, low levels of ~ mRNA were first detectable in the thymus on (26) (27) (28) (29) . O n the other hand, "/predominates in fetal thymocytes during stages that precede expression of the clonotypic T C R -o t and TCR-[3 genes (Fig. 1 ). The striking difference in expression of y and ~ during ontogeny suggested that these proteins might play distinctive roles in thymocyte development. To investigate this possibihty, we perturbed the normal pattern of~/expression by generating transgemc mice in which ~/ is overexpressed in early thymocytes and continues to be expressed throughout development.
Generation of FcERI y Transgenic Mice. The Fc~P, Iy (y)
transgene was generated from a 4.8-kb BclI genomic fragment contaimng the human y promotor and coding sequences and a 5-kb genomic fragment containing the human CD2 3'-enhancer element (18, 21; 
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• ." '-r ;.
14 . transgene expression relative to endogenous y was assessed by sequentlai hybridization of northern blots with human and mouse cDNA probes followed by densitometric quantitation. Transgene expression was estimated to be 50-fold (Tg line y371) to 600-fold (Tg line 3'551) greater than endogenous m adult thymocytes. In fetal day 15.5 thymocytes, the relative increase was less due to the higher level of endogenous y; 5-fold in Tg line y371 and 60-fold in Tg line y551 (not shown).
Immunoblotting with antiserum that detects both human and murine 3' chains demonstrated the presence of human 3' chain in adult thymocytes from Tg mice (Fig. 2 C-) . After prolonged exposure, a far less abundant protein of identical mobility, representing endogenous murine y, was also observed in thymocytes from nontransgemc mice (not shown). Given the high level of sequence conservation between human and murine y chains (18) it was expected that these proteins would be functionally equivalent. Consistent with this idea, transgene-encoded human 3' chains assembled both as homodimers and as heterodimeric forms with endogenous murine { chain (not shown). Analysis of proteins from both adult and fetal (day 17.5) thymocytes by two-dimensional SDS-PAGE revealed that both {y and yy dimers were present in thymocytes from 3'Tg mice and their relative abundance predictably increased with transgene copy number. In contrast, ~3' and y3" dimers were virtually undetectable in adult nontransgenic mice (not shown).
Dose-related Effects of the T Transgene on Thymocyte Development.
To determine the effect of 3" overexpression on T cell development, we first analyzed the phenotype of adult thymocytes from control and 3'Tg mice. Thymocyte numbers were reduced in yTg mice ( Fig. 3 progressive reduction in thymocyte number with increasing transgene copy number ( Fig. 3 ; Table 1 ). Analysis of CD4 and CD8 expression on thymocytes from ~/Tg mice revealed an impairment of thymocyte maturation. Low copy number transgenic lines exhibited minimal developmental defects whereas high copy number transgenic lines exhibited a progressive loss of mature CD4+CD8 -or CD4-CD8 + (single positive, SP) and CD4+CD8 + (double positive, DP) thymocytes and a relative increase in the number of immature CD4-CD8-(double negative, DN) thymocytes ( Fig. 3 ; Table 1 ). y overexpression also resulted in a corresponding reduction in the number of peripheral T cells (Fig. 3) . Both DP and SP thymocytes from yTg mice expressed ot/[3TC1L (Fig. 3) . In fact, though reduced in number, DP thymocytes from adult yTg mice expressed higher levels of ot/[3TClK than DP thymocytes from nonTg mice (Fig. 3, data not shown) . Moreover, despite their reduced numbers, peripheral CD4 + and CD8 + T cells from yTg mice expressed ot/[3TCIL at levels comparable to controls (Fig. 3) . Overexpression of~/did not result in complete developmental arrest, as all thymocyte subsets (DN, DP, and SP) as well as peripheral T cells were present in adult ~Tg mice. The phenotype of adult yTg mice additionally suggested a block in early thymocyte development. Numbers of DP thymocytes were markedly reduced in high copy number ("/551) Tg mice (DN/DP ratio of 1.0 + 0.26; n = 5 compared to 0.03 + 0.01; n = 5 for controls). In contrast, the transition of DP thymocytes into mature, SP thymocytes appeared less affected as the SP/DP ratio in "y551 Tg mice (0.16 + 0.05; n = 5), was identical to that of control mice (0.11 ---0.03; n = 5). Interestingly, although both CD4 + CD8-SP and CD4-CD8 + SP thymocyte numbers were reduced in ~Tg mice, CD4+CD8 -thymocytes appeared to be more severely affected ( Fig. 3; Table 1 ). A skewed ratio of CD4+CD8 to CD4-CD8 + cells was also seen in the lymph nodes of yTg mice indicating that the development ofCD4+CD8 -T cells may be selectively impaired (Fig. 3) .
y Overexpression Delays Maturation of c~/IgTCR + T Cells. To determine when the developmental impairment was first evident in "/Tg mice we next analyzed pro- gressive stages of fetal thymocyte maturation. Examination of fetal thymocytes from high copy number ("/551) Tg mice revealed an early perturbation of thymocyte maturation (Figs. 4 and 5) . Total numbers of thymocytes were equivalent in control and "/551 Tg mice on day 15, but at all subsequent stages, the number of thymocytes in ~/Tg mice was reduced relative to nontransgenic mice (Fig. 4) . By fetal day 17.5, significant numbers of "transitional," CD4-CD8 l° and DP thymocytes were detectable in normal mice, whereas most thymocytes in the y551 Tg mice remained DN (Fig. 5 A) . DP and SP thymocytes began to accumulate in ",/551 Tg mice only after birth and the relative number of DN thymocytes remained high even in adult mice (Figs. 3 and 5) . Thymocytes from y551Tg mice were immature relative to nontransgenic mice of the same gestational age by several other criteria. For example, most thymocytes from "/551 transgenic newborn mice resembled fetal thymocytes in that they were IL2-1Kot + and expressed low levels of surface CD2, CD5, and ot/[3TC1K (Fig. 5 B) .
Fetal Thymocyte Development Is Delayed at the CD4-CD8-FcTRII/III + Stage in yTg
Mice. Since our analysis of fetal thymocytes 8om ~/Tg mice revealed a block at the DN--+DP transition stage, we examined the phenotype of early DN thymocyte populations in yTg mice. Four distinct subsets of precursor "triple negative" (CD3-CD4-CD8-) thymocytes have been identified on the basis of CD44 and CD25 expression that represent progressive stages of development: CD44+ CD25---+CD44+ CD25 +-->CD441°/-CD25+ --+CD44-CD25- (30) . FACS ® analysis of DN thymocyte subsets from newborn ~/Tg mice revealed a specific block in development at the CD44+/l°CD25 + stage (Fig. 5 C-' ). The reduction in CD44-CD25 triple negative thymocytes was Total thymocytes were stained with blotmylated antl-CD3, -CD4, -CD8, -B220 plus avldm-R670, FITC-ann-CD44, and PE-antiCD25. CD44 and CD25 surface expression was determined on CD3-, 4-,8-, B220-(max) negative thymocytes by gating. Mix-negative thymocytes were determined to be Thy 1.2 + by separate staining. consistent with the low numbers of DP thymocytes observed m ",/Tg mice as these cells are the immediate precursors of DP thymocytes (30) . Since ",/chain is known to associate with FcyRIII we next examined expression of Fc',/ receptors on early thymocyte populations. Staining of fetal day 15.5 thymocytes with mAb 2.4G2 (31), which recognizes the FcyRIIb D Fc'yRIIb 2, and Fc'yRIII receptor isoforms, revealed that the majority of thymocytes from control and ~/551 Tg mice expressed FcyRII and/or Fc'yRIII ( Fig. 6 A, and reference 5) . The specificity of staining with mAb 2.4G2 was established by demonstrating that it could be blocked by unconjugated 2.4G2, but not by unconjugated isotype-matched mAb (not shown). In nontransgenic mice, the percentage of Fo/RII/III + (2.4G2 +) thymocytes decreased rapidly during gestation (Fig. 6 A, and reference  5 ). In contrast, the percentage of FcyRII/III + thymocytes remained high in "y551Tg mice throughout fetal development (Fig. 6 A) . Because total cellularity was reduced in "y551Tg mice (Fig. 4) , the total number of FcyRII/III + thymocytes was nevertheless equivalent to that of controls.
Moreover, FcyRII/III + thymocytes from fetal day 17.5 control and "y551Tg mice appeared phenotypically sirmlar (i.e., Thy-I+CD4-CD8 CD3-HSA+; data not shown). These findings suggested that the high percentage of Fc'yRII/III + thymocytes in "yTg fetal mice reflected their failure to progress further in development.
Recent work has shown that loss of FcI, RII/III surface expression precedes the differentiation of early CD3-CD4-CD8-thymocytes to the DP stage (i.e., DN Fcy-RII/III+-+DN Fc~/RII/III--+DP FcyRII/III-; [32] ). To determine if thymocyte development was blocked at the DN Fo/RII/III+-+DN FcyRII/III-transition stage in y551Tg mice, we examined the surface expression of Fcy-RII/III on fetal DN thymocytes. In nontransgenic mice, the percentage of DN thymocytes that express Fc~/RII/III decreased from 61% at fetal day 15.5 to 32% at fetal day 17.5, and those cells that remained positive expressed reduced levels of Fc~/RII/III (Fig. 6 B) . Significant numbers of DP thymocytes were first detected in nontransgenic mice on fetal day 17.5 ( Fig. 6 B) 
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same interval (fetal day 15.5-17.5), DN thymocytes from yTg mice failed to differentiate into DP thymocytes, remained predominantly Fc'yRII/III + and continued to express high levels of Fc',/RII/III (Fig. 6 B) . Appreciable
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Analysis of Fc'yPdI/III expression on CD4-CD8-and CD4+CD8 + thymocytes from newborn "/551Tg mace. Two-color plots show CD4 vs. CD8 stalmng. Single-color plots show 2.4G2 staining on Thy-l.2 + CD4-CD8-thymocytes (left) or CD4+CD8 + thymocytes (right). Thy-l.2 + CD4-CD8-were analyzed as described in B; CD4+CD8 + thymocytes were analyzed by stalmng v~th anfi-CD4-FITC, then anti-CD8-PE, then blounylated 2.4G2 plus avldin-Red 670 Gating on CD4 + CD8 + thymocytes was performed at the tmle of data collection. Dotted hne represents staining with control antibody.
numbers ofDN Fc~/RII/III-thymocytes were first detectable in newborn y551Tg mice, indicating that their formation was delayed relative to control mice (Fig. 6 C) Proteins were transferred to nitrocellulose and blotted with a 1:1,000 dilution of ann-"/sera Immunoreactxve proteins were detected by chemiluminescence. Exposure Umes were 30 s for Non Tg samples and 3 s for "/Tg samples ~/551Tg mice coincided with the appearance of DP thymocytes, which were also F c y R I I / I I I - (Fig. 6 C) . Collectively, these observations indicate that y overexpression delays the maturation o f D N Fc~/R.II/III + thymocytes.
Expression of FcTRllI in Fetal 77zymocytes
. mAb 2.4G2 reacts with three distinct F c y R isoforms (tklIbl, RIIb 2, and Rill) only one of which (Fc',/RIII) is known to associate with y chain. Consequently, we were interested in determining whether the 2.4G2 staining on fetal thymocytes from 3'551Tg mice reflected expression o f Fc',/tLIII. R everse transcription-PCR analysis demonstrated that transcripts for both FcyP, IIb and FcyRIII (5; data not shown) are expressed in both fetal and newborn thymocytes from control and ~/551Tg mice. The presence of FcyRIII (ix + y) complexes was then assessed by immunopreclpitation with m_Ab 2.4G2 followed by immunoblotting with anti-y chain sera. As shown in Fig. 7 , y chain could be coprecipitated with mAb 2.4G2 from both nonTg and y551Tg fetal day 17.5 thymocyte lysates. However, the amount o f c o i m m unopreclpitated y chain was significantly greater in thymocyte lysates from fetal day 17.5 y551Tg mice.
Impaired NK Cell Development in yTg Mice. In view of recent data indicating that at least some N K cells may originate from early Fc~/RIII + thymocyte progenitors (5, 6), we assessed whether N K cell development was compromised in ~/Tg mice. Analysis o f splenocytes (Fig. 8 A) and PBL (not shown) demonstrated that the number of N K 1.1 + cells was reduced in y551Tg mice relative to nontransgenic controls. In contrast, B cell numbers were normal or elevated in these mice (Fig. 8 A) . As with T cells (indicated by staining with anti-Thy 1.2), the reduction in NKI.1 + cells was transgene dose dependent (Fig. 8 A) . To assess N K activity, nontransgenic and ~/551 Tg mice were injected with poly(IC) and spleen cells were assayed for cytotoxicxty against the NK-sensitive target cell, YAC-1, and for A D C C . Consistent with the FACS ® analysis, N K activity and A D C C were negligible in y551 Tg mice (Fig. 8 B) . Taken together, these results demonstrate that the number of N K cells is markedly reduced in y551 Tg mice.
Discussion
The present study was directed at exploring a possible role for F c e R b / i n thymocyte development. Northern blot analysis of fetal and adult thymocytes demonstrate that ~/is expressed in the fetal thymus: expression is highest at early stages (fetal day 13.5-15.5), and decreases progressively with gestational age. This pattern contrasts sharply with that o f the structurally and functionally related ~ chain, which is expressed later in development and functions primarily as a signal-transducing subumt of the ix/[3TCtL complex. In view of these results, we generated transgenic mice that overexpress ",/, reasoning that a perturbation of thymocyte maturation, if observed, might yield insight into its function in early thymocytes. Analysis of multiple transgenic founder lines revealed that y overexpression does indeed impair early thymocyte development. The transgene effects are dose related and result in delayed maturation of fetal D N thymocytes, with less severe effects on later stages of development.
Analysis of fetal thymocytes from high copy number y551Tg mice revealed that ~/chain overexpression specifically blocked thymocyte development at the D N CD25 + (5), it is notable that N K cell development was likewise impaired in ~/Tg mice. Further support for the idea that T and N K cells share a c o m m o n precursor is provided by the observation that perturbation of both T cell and N K cell development was also observed in transgenic mice in which human CD3e was overexpressed in early thymocytes (33) .
One interpretation of our observations is that the ~/transgene-induced effects are mediated by Fc2*tLIII (CD16) complexes on early thymocytes. Although the mAb used to assess F c y R I I / I I I surface expression does not distinguish between these isoforms and therefore does not enable specific quantitative evaluation of FcyRIII surface expression, Western blot analysis is consistent with the idea that y is associated with FcyRIIIix in both nontransgenic and ~/Tg fetal thymocytes. However, fetal day 17.5 thymocytes from y551Tg mice, which express high surface levels of Fc2/RII/III, con- Seemingly inconsistent with our data is the observation that both T and NK cell development are unaffected in mice rendered "g chain deficient by gene targeting (19) . Those results argue that if Fc~RIII constitutes a competent signal-transducing complex m early thymocytes, such signals are not essential for thymocyte or NK cell maturation. Although this inconsistency could be explained by functional redundancy, our results favor a hypothesis in which y chain provides a negative regulatory signal during development. Increased or prolonged signaling by Fc',/RIII could therefore result in maturational delay, whereas absence of these signals might either appear phenotypically silent or result in accelerated differentiation. In support of this idea is the observation that DN FcyRII/III + thymocytes are developmentally delayed relative to DN Fc~RII/III-thymocytes (32) , and that in fetal thymic organ culture, treatment with mAb 2.4G2, which presumably blocks binding of Fo/R.II/III to their natural ligand(s), accelerates thymocyte differentiation (20) . Fc',/RIII could function as an early signaling structure expressed on thymocytes before the rearrangement and expression of the clonotyplc <x/I3TCP,.
complex. Triggering of Fo/P,.III might occur either by direct interaction with its putative ligand or, as suggested previously (5), by its serving as a coreceptor to couple other surface structures (e.g., Thy-1 or CD2) to intracellular signal transduction pathways.
It is also possible that "y chain overexpression inhibits thymocyte development through indirect effects. Fc',/RIII overexpression could inhibit thymocyte development through sequestration of developmentally important molecules. For example, sequestration of p56 Ick, which has been shown to interact with "y chain as part of the Fc~/RIII complex (34), might result in developmental effects such as those described here. In addition, although "y does not associate directly with Fc'yP,.II, surface expression of this receptor may also be increased or its expression prolonged in "gTg mice. Fcyt<II has been shown to act as a negative regulator of hematopoetic cell activation (35) ; therefore its failure to be down-regulated in early thymocytes could be inhibitory. Since mAb 2.4G2 does not distinguish between Fc3'RII and Fc3'R.III we were unable to discern the relative expression of these receptors in non-Tg and 3' Tg mice. However, both we (data not shown) and others (5) have detected Fc3'P, IIb expression during fetal thymocyte development by reverse transcription-PCP,. Notwithstanding, two lines of evidence indicate that the developmental effects observed in 3'Tg mice are specific to y chain. First, we have previously shown that overexpression of both ~1 chain or a truncated form of ~ chain that, like y, contains only a single ITAM does not inhibit thymocyte maturation (22) . Second, reconstitution of~-deficient (~-/-) mice with y transgenes revealed that the phenotype ofyTg mice is identical regardless of the presence of absence of endogenous ~ chain (data not shown). These results indicate that the developmental effects of y overexpression are not the result of its association with ~ chain or due to competition with ~ chain for association with other molecules.
The phenotype of 3'Tg and ~Tg mice also provides Insight into the function of these molecules in developing thymocytes. Although T cell development is adversely affected in both ~ and 3' transgenic mice, their phenotypes are strikingly different, y chain overexpression delays, but does not arrest, thymocyte development at the DN Fc3'P, II/III + stage, whereas ~ chain overexpression results in a near complete arrest at a later stage of development (22) . Fetal thymocytes from ~Tg mice but not 3'Tg mice are further distinguished by their inappropriate expression of activation markers and premature down-regulation of P, agl and II.ag2 (22) . These data suggest that y and { may couple to different signaling pathways in early thymocytes. One possibility is that y and ~ associate preferentially with different cell surface structures, e.g., ~ chain along with the CD3 subunits as part of the pre-TCR and oe/[3TCP, complexes, and 3' chain with the Fc3'RIII complex. Indeed, the distinctive patterns of 3' and ~ expression during gestation would be consistent with this idea.
